Arterial hypertension and longevity

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Longevity is the phenomenon of increasing human life expectancy. A large number of works are devoted to the study of the processes of aging of the body and the accumulation of pathology in it. It is customary to distinguish several factors of longevity: certain stages of natural aging, factors of the external and internal environment of the body, genetic predisposition. An important factor in the reduction of life is the incidence and mortality from cardiovascular events. Prevention and treatment of cardiovascular diseases, including arterial hypertension, is a priority direction in longevity achievement.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Elena Reznik

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia; City Clinical Hospital No. 31 of the Department of Healthcare of Moscow

Email: elenaresnik@gmail.com
Dr. med. habil., associate professor, head of the Department of propaedeutics of internal diseases of the Faculty of general medicine; cardiologist, therapist

Yuri Golubev

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

PhD in Medicine, associate professor of the Department of propaedeutics of internal diseases of the Faculty of general medicine

Alexander Zhuravlev

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

Email: al.zhuravleff@mail.ru
Dr. med. habil., professor, professor of the Department of propaedeutics of internal diseases of the Faculty of general medicine

Natalya Yurtaeva

Central Polyclinic of the Federal Security Service of Russia

functional diagnostics doctor

Galina Ischenko

Central Clinical Hospital of St. Alexis, Metropolitan of Moscow, Moscow Patriarchy of the Russian Orthodox Church

PhD in Medicine, therapist

Әдебиет тізімі

  1. Бойцов С.А., Погосова Н.В., Бубнова М.Г. с соавт. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018; 23(6): 7-122. [Boytsov S.A., Pogosova N.V., Bubnova M.G. et al. Cardiovascular prevention 2017. National guidelines. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 23(6): 7-122 (In Russ.)]. http://dx.doi.org/10.15829/1560-4071-2018-6-7-122. EDN: XSLTTF.
  2. Hjelmborg J., Iachine I., Skytthe A. et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006; 119(3): 312-21. http://dx.doi.org/10.1007/s00439-006-0144-y.
  3. Добротворская С.Г. Факторы саморазвития и здорового долголетия человека. Монография. Казань: Центр инновационных технологий. 2007; 134 с.
  4. Кобалава Ж.Д., Конради А.О., Недогода С.В. с соавт. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(3): 149-218. [Kobalava Zh.D., Konradi A.O., Nedogoda S.V. et al. Arterial hypertension in adults. Clinical guidelines 2020. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(3): 149-218 (In Russ.)]. http://dx.doi.org/10.15829/1560-4071-2020-3-3786. EDN: TCRBRB.
  5. Ткачева О.Н., Рунихина Н.К., Котовская Ю.В. с соавт. Лечение артериальной гипертонии у пациентов 80 лет и старше и пациентов со старческой астенией. Кардиоваскулярная терапия и профилактика. 2017;1 6(1): 8-21. [Tkacheva O.N., Runikhina N.K., Kotovskaya Yu.V. et al. Arterial hypertension management in patients aged older than 80 years and patients with the senile asthenia. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2017; 16(1): 8-21 (In Russ.)]. http://dx.doi.org/10.15829/1728-8800-2017-1-8-21. EDN: YFZRJT.
  6. Демографический ежегодник России. 2015. Статистический сборник. М.: Росстат. 2015; 263 с. [Demographic yearbook of Russia. 2015. Statistical compendium. Moscow: Rosstat. 2015; 263 pp. (In Russ.)]. ISBN: 978-5-89476-414-6.
  7. Butt D.A., Harvey P.J. Benefits and risks of antihypertensive medications in the elderly. J. Intern Med. 2015; 278(6): 599-626. http://dx.doi.org/10.1111/joim.12446.
  8. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national agesex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385(9963): 1 17-71. http://dx.doi.org/10.1016/S0140-6736(14)61682-2.
  9. O'Donnell M.J., Chin S.L., Rangarajan S. et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016; 388(10046): 761-75. http://dx.doi.org/10.1016/S0140-6736(16)30506-2.
  10. Tsao C.W., Aday A.W., Almarzooq Z.I. et al. Heart disease and stroke statistics-2022 update: A report from the American Heart Association. Circulation. 2022; 145(8): e153-e639. http://dx.doi.org/10.1161/CIR.0000000000001052.
  11. Муромцева Г.А., Концевая А.В., Константинов В.В. с соавт. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014; 13(6): 4-11. http://dx.doi.org/10.15829/1728-8800-2014-6-4-11. EDN: TBSOYN.
  12. Недогода С.В. Результаты исследования HYVET: значение для клинической практики. Кардиоваскулярная терапия и профилактика. 2008; 7(5): 76-80. [Nedogoda S.V. HYVET Study results: importance for clinical practice. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2008; 7(5): 76-80 (In Russ.)]. EDN: JSJDYV.
  13. Fryar C.D., Ostchega Y., Hales C.M. et al. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS Data Brief. 2017; 289: 1-8.
  14. Аксенова А.В., Ощепкова Е.В., Орловский А.А., Чазова И.Е. Артериальная гипертония у больных пожилого и старческого возраста: клиническая характеристика и качество лечения (по данным национального регистра артериальной гипертонии). Сибирский медицинский журнал. 2019; 34(3): 73-86. http://dx.doi.org/10.29001/2073-8552-2019-34-3-73-86. EDN: FDGRFK.
  15. Battson M.L., Lee D.M., Weir T. L., Gentile C.L. The gut microbiota as a novel regulator of cardiovascular function and disease. J. Nutr Biochem. 2018; 56: 1-15. http://dx.doi.org/10.1016/j.jnutbio.2017.12.010.
  16. Ley R.E., Backhed F., Turnbaugh P. et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U. S. A. 2005; 102(31): 11070-75. http://dx.doi.org/10.1073/pnas.0504978102.
  17. Zhu W., Gregory J.C., Org E. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016; 165(1): 11 1-24. http://dx.doi.org/10.1016/jxell.2016.02.011
  18. Ziganshina E.E., Sharifullina D.M., Lozhkin A.P. et al. Bacterial communities associated with atherosclerotic plaques from Russian individuals with atherosclerosis. PLoS One. 2016; 11(10): e0164836. http://dx.doi.org/10.1371/journal.pone.0164836.
  19. Santisteban M.M., Qi Y., Zubcevic J. et al. Hypertension-linked pathophysiological alterations in the gut. Circ Res. 2017; 120(2): 312-23. http://dx.doi.org/10.1161/CIRCRESAHA.116.309006.
  20. Sabayan B., Oleksik A.M., Maier A.B. et al. High blood pressure and resilience to 45 physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J. Am Geriatr Soc. 2012; 60(1 1): 2014-19. http://dx.doi.org/10.1111/j.1532-5415.2012.04203.x.
  21. Taekema D.G., Maier A.B., Westendorp R.G., de Craen A.J. Higher blood pressure is associated with higher handgrip strength in the oldest old. Am J. Hypertens. 2011; 24(1): 83-89. http://dx.doi.org/10.1038/ajh.2010.185.
  22. Суслина З.А., Гераскина Л.А., Фонякин А.В. Актуальные вопросы и рациональный подход к лечению артериальной гипертонии при сосудистой патологии мозга. Кардиоваскулярная терапия и профилактика. 2005; 4(3-1): 82-87. [Suslina Z.A., Geraskina L.A., Fonyakin A.V. Antihypertensive therapy in patients with cerebrovascular pathology: actual aspects and rational approaches. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2005; 4(3-1): 82-87 (In Russ.)]. EDN: ISVWOB.
  23. James P.A., Oparil S., Carter B.L. et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 31 1(5): 507-20. http://dx.doi.org/10.1001/jama.2013.284427.
  24. Muntner P., Carey R., Gidding S. et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018; 137(2): 109-18. http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032582.
  25. ЕОК/ЕОАГ Рекомендации по лечению больных с артериальной гипертензией. Российский кардиологический журнал. 2018; 23(12): 143-228. [2018 ESC/ESH Guidelines for the management of arterial hypertension. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 23(12): 143-228 (In Russ.)]. http://dx.doi.org/10.15829/1560-4071-2018-12-143-228. EDN: SLRUJJ.
  26. Verdecchia P., Angeli F., Mazzotta G. et al. Aggressive blood pressure lowering is dangerous: the J-curve: con side of the argument. Hypertension. 2014; 63(1): 37-40. http://dx.doi.org/10.1161/01.hyp.0000439102.43479.43.
  27. Somes G.W., Pahor M., Shorr R.I. et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999; 159(17): 2004-9. http://dx.doi.org/10.1001/archinte.159.17.2004.
  28. Sander G.E. High blood pressure in the geriatric population: Treatment consideration. Am J Geriatr Cardiol. 2002; 1 1(4): 223-32. http://dx.doi.org/10.1111/j.1076-7460.2002.00032.x
  29. Xu W., Tan L., Wang H.-F. et al. Meta-analysis of modifiable risk factors for Alzheimer's disease. J. Neurol Neurosurg Psychiatry. 2015; 86(12): 1299-306. http://dx.doi.org/10.1136/jnnp-2015-310548.
  30. Kocyigit S.E., Soysal P., Bulut E.A. et al. What is the relationship between frailty and orthostatic hypotension in older adults? J. Geriatr Cardiol. 2019; 16(3): 272-79. http://dx.doi.org/10.1 1909/j.issn.1671-541 1.2019.03.005.
  31. Wojszel Z.B., Kasiukiewicz A., Magnuszewski L. Health and functional determinants of orthostatic hypotension in geriatric ward patients: a retrospective cross sectional cohort study. J. Nutr Health Aging. 2019; 23(6): 509-17. http://dx.doi.org/10.1007/s12603-019-1201-2.
  32. Liguori I., Russo G., Coscia V. et al. Orthostatic hypotension in the elderly: A marker of clinical frailty? J. Am Med Dir Assoc. 2018; 19(9): 779-85. http://dx.doi.org/10.1016/j.jamda.2018.04.018.
  33. Mol A., Slangen L.R.N., Trappenburg M.C. et al. Blood pressure drop rate after standing up is associated with frailty and number of falls in geriatric outpatients. J. Am Heart Assoc. 2020; 9(7): e014688. http://dx.doi.org/10.1161/JAHA.119.014688.
  34. Vetrano D.L., Palmer K.M., Galluzzo L. et al. Hypertension and frailty: A systematic review and meta-analysis. BMJ Open. 2018; 8(12): e024406. http://dx.doi.org/10.1136/bmjopen-2018-024406.
  35. Петрова М.М., Остроумова О.Д., Черняева М.С. Современные представления о проблеме ортостатической гипотензии. Комплексные проблемы сердечно-сосудистых заболеваний. 2019; 8(4): 116-126. http://dx.doi.org/10.17802/2306-1278-2019-8-4-116-126. EDN: EJTNFP.
  36. Wojszel Z.B., Kasiukiewicz A., Magnuszewski L. Health and functional determinants of orthostatic hypotension in geriatric ward patients: a retrospective cross sectional cohort study. J. Nutr Health Aging. 2019; 23(6): 509-17. http://dx.doi.org/10.1007/s12603-019-1201-2.
  37. Ahmed A.M., Dalia Ahmed D., Alfaris M. et al. Prevalence and predictors of frailty in a high-income developing country: a cross-sectional study. Qatar Med J. 2020; 2019(3): 20. http://dx.doi.org/10.5339/qmj.2019.20.
  38. Kang M., Kim S., Yoon S-J. et al. Association between frailty and hypertension prevalence, treatment, and control in the elderly Korean population. Sci Rep. 2017; 7(1): 7542. http://dx.doi.org/10.1038/s41598-017-07449-5.
  39. Wing L.M., Reid C.M., Ryan P. et al. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl J. Med. 2003; 348(7): 583-92. http://dx.doi.org/10.1056/NEJMoa021716.
  40. Ogihara T., Hiwada K., Morimoto S. et al. Guidelines for treatment of hypertension in the elderly - 2002 revised version. Hypertens Res. 2003; 26(1): 1-36. http://dx.doi.org/10.1291/hypres.26.1.
  41. Wei Y., Jin Z., Shen G. et al. Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years. J. Clin Hypertens (Greenwich). 2013; 15(6): 420-27. http://dx.doi.org/10.1111/jch.12094.
  42. Jatos Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008; 31(12): 2115-27. http://dx.doi.org/10.1291/hypres.31.2115.
  43. Wing L.M., Reid C.M., Ryan P. et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl J. Med. 2003; 348(7): 583-92. http://dx.doi.org/10.1056/NEJMoa021716.
  44. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358(9287): 1033-41. http://dx.doi.org/10.1016/S0140-6736(01)06178-5.
  45. Gosse P., Sheridan D.J., Zannad F. et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J. Hypertens. 2000; 18(10): 1465-75. http://dx.doi.org/10.1097/00004872-200018100-00015.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2022

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>